(Q28253671)

Chromatin remodeling and cancer

21 January 2018

1 reference

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 January 2018

1 reference

Oncogenomics and the development of new cancer therapies

21 January 2018

1 reference

Differentiation therapy for acute promyelocytic leukemia

31 March 2020

1 reference

All-trans-retinoic acid in acute promyelocytic leukemia

31 March 2020

1 reference

Tumor taxonomy for the developmental lineage classification of neoplasms

31 March 2020

1 reference

Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches

31 March 2020

1 reference

Epithelial-mesenchymal transitions in tumour progression

31 March 2020

1 reference

Epithelial-mesenchymal transitions: twist in development and metastasis

31 March 2020

1 reference

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation

31 March 2020

1 reference

Chromatin remodeling in development and differentiation.

31 March 2020

1 reference

A panorama of lineage-specific transcription in hematopoiesis

31 March 2020

1 reference

The molecular basis of lung morphogenesis

31 March 2020

1 reference

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

31 March 2020

1 reference

The language of covalent histone modifications

31 March 2020

1 reference

Chromatin disruption and modification

31 March 2020

1 reference

DNA methylation patterns and epigenetic memory

31 March 2020

1 reference

ATP-dependent chromatin-remodeling complexes.

31 March 2020

1 reference

Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins

31 March 2020

1 reference

Positional information and pattern formation in development

31 March 2020

1 reference

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

31 March 2020

1 reference

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

31 March 2020

1 reference

BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.

31 March 2020

1 reference

Deregulated homeobox gene expression in cancer: cause or consequence?

31 March 2020

1 reference

The pathophysiology of HOX genes and their role in cancer.

31 March 2020

1 reference

Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers

31 March 2020

1 reference

Rules for making human tumor cells

31 March 2020

1 reference

31 March 2020

1 reference

Mutations of the BRAF gene in human cancer

31 March 2020

1 reference

Tissue, cell and stage specificity of (epi)mutations in cancers

31 March 2020

1 reference

The INK4a/ARF locus and melanoma

31 March 2020

1 reference

Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.

31 March 2020

1 reference

Redundant cyclin overexpression and gene amplification in breast cancer cells

31 March 2020

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

31 March 2020

1 reference

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

31 March 2020

1 reference

Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group

31 March 2020

1 reference

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

31 March 2020

1 reference

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis

31 March 2020

1 reference

"Lineage addiction" in human cancer: lessons from integrated genomics

31 March 2020

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

31 March 2020

1 reference

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

31 March 2020

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

31 March 2020

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

31 March 2020

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

How to become neural crest: from segregation to delamination.

31 March 2020

1 reference

Development of melanocyte precursors from the vertebrate neural crest.

31 March 2020

1 reference

Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.

31 March 2020

1 reference

From integrated genomics to tumor lineage dependency

31 March 2020

1 reference

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF

31 March 2020

1 reference

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

31 March 2020

1 reference

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

31 March 2020

1 reference

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression

31 March 2020

1 reference

The genetics of malignant melanoma: lessons from mouse and man.

31 March 2020

1 reference

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes

31 March 2020

1 reference

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

31 March 2020

1 reference

Androgen receptor in prostate cancer

31 March 2020

1 reference

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells

31 March 2020

1 reference

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

31 March 2020

1 reference

Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

31 March 2020

1 reference

The reciprocal dance between cancer and development

31 March 2020

1 reference

31 March 2020

Role of FLT3 in leukemia

1 reference

The role of FLT3 in haematopoietic malignancies

31 March 2020

1 reference

Functional domains of the human estrogen receptor

31 March 2020

1 reference

Steroid receptors in human breast cancer

31 March 2020

1 reference

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

31 March 2020

1 reference

Thyroid transcription factor-1.

31 March 2020

1 reference

Thyroid transcription factor 1 in pulmonary adenocarcinoma

31 March 2020

1 reference

Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor

31 March 2020

1 reference

The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin

31 March 2020

1 reference

The Cdx-1 and Cdx-2 homeobox genes in the intestine

31 March 2020

1 reference

Homeobox gene Cdx1 regulates Ras, Rho and PI3 kinase pathways leading to transformation and tumorigenesis of intestinal epithelial cells.

31 March 2020

1 reference

Genetic predisposition to colorectal cancer

31 March 2020

1 reference

The retinoblastoma tumour suppressor in development and cancer

31 March 2020

1 reference

Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors

31 March 2020

1 reference

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients

31 March 2020

1 reference

Multiclass cancer diagnosis using tumor gene expression signatures

31 March 2020

1 reference

Stem cells in the etiology and treatment of cancer

31 March 2020

1 reference

Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment

31 March 2020

1 reference

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

The concept of synthetic lethality in the context of anticancer therapy

31 March 2020

1 reference

Principles for the buffering of genetic variation

31 March 2020

1 reference

Choosing anticancer drug targets in the postgenomic era.

31 March 2020

1 reference

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

31 March 2020

1 reference

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

31 March 2020

1 reference

Antisense therapy in oncology: new hope for an old idea?

31 March 2020

1 reference

Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer

31 March 2020

1 reference

Cancer stem cells: lessons from leukemia.

31 March 2020

1 reference

Tumour stem cells and drug resistance

31 March 2020

1 reference

Using high-throughput SNP technologies to study cancer

31 March 2020

1 reference

Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays

31 March 2020

1 reference

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays

31 March 2020

1 reference

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

31 March 2020

1 reference

The origin of the cancer cell: oncogeny reverses phylogeny

31 March 2020

1 reference